Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Venetoclax with Hypomethylating Agents Versus Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia with Myelodysplasia Related Changes: A Propensity Score Matched Analysis Based on International Consensus Classification

Chao-Ling Wan, Yu-Qing Liu, Fang-Tong Liu, Yuan-Hong Huang, Han-Yu Cao, Si-Man Huang, Kai-Wen Tan, Zihao Wang, Shuai-Shuai Ge, Miao Wang, Haiping Dai, Sheng-Li Xue

Blood (2024) 144 (Supplement 1): 1527.

https://doi.org/10.1182/blood-2024-197933

Published: 2024

Journal Articles

Favorable Safety Profile and Durable Responses to Pmb-CT01 (BAFFR-CAR T Cell) Therapy in Patients with B-Cell Lymphomas Ineligible for or Who Failed CD19-Targeted Therapy, Including CD19-Negative Disease

Marissa Morales Del Real, John H. Baird, Lu Chen, Joo Y. Song, Xiuli Wang, Swetha Kambhampati, Alan Macias, Emanuela C Marcucci, Soungchul Cha, Zhenyuan Dong, Teresa Kim, Baishakhi Barva, Sandrine Puverel, Qing Liu-Michael, Hazel Ting-Ying Cheng, Stephen J. Forman, Larry W. Kwak, Lihua E. Budde

Blood (2024) 144 (Supplement 1): 3127.

https://doi.org/10.1182/blood-2024-198416

Published: 2024

Journal Articles

Venetoclax with Hypomethylating Agents Compared with Priming Regimens for Newly Diagnosed Patients with Acute Myeloid Leukemia with Myelodysplasia Related Changes: A Single Center Retrospective Study

Fangtong Liu, Chao-Ling Wan, Yu-Qing Liu, Yuan-Hong Huang, Han-Yu Cao, Si-Man Huang, Kai-Wen Tan, Shuai-Shuai Ge, Miao Wang, Mei-Jing Liu, Zihao Wang, Sheng-Li Xue, Haiping Dai

Blood (2024) 144 (Supplement 1): 1484.

https://doi.org/10.1182/blood-2024-202500

Published: 2024

Journal Articles

Prime Editing of the α-Thalassemia Hb Constant Spring Mutation

Congwen Shao, Qing Liu, Jinchao Xu, Ye Xin, Jianxiang Zhang, Yuhua Ye, Hualei Luo, Xinhua Zhang, Xiangmin Xu, Peng Xu

Blood (2023) 142 (Supplement 1): 5001.

https://doi.org/10.1182/blood-2023-185425

Published: 2023

Journal Articles

Naturally Occurring Mutations in Human T Cell Lymphomas Enhance Engineered T Cell Therapies

Julie Garcia, Jay Daniels, Yujin Lee, Iowis Zhu, Kathleen Cheng, Qing Liu, Daniel Goodman, Cassandra Burnett, Calvin Law, Chloe Thienpoint, Josef Alavi, Camillia Azimi, Garrett Montgomery, Kole Roybal, Jaehyuk Choi

Blood (2023) 142 (Supplement 1): 884.

https://doi.org/10.1182/blood-2023-180895

Published: 2023

Journal Articles

The Novel Biomarkers for Predicting Prognosis and Recurrence in Primary Central Nervous System Lymphoma: Exosomal Protein and Exosomal microRNA

Liwei Lv, Xuefei Sun, Yuchen Wu, Huanguang Liu, Wenyuan Lai, Qu Cui, Yuedan Chen, Qing Liu, Ruixian Xing, Xueyan Bai, Jun Qian, Jingjing Lu, Shengjun Sun, Fangang Meng, Nan Ji, Yuanbo Liu

Blood (2023) 142 (Supplement 1): 6123.

https://doi.org/10.1182/blood-2023-184544

Published: 2023

Journal Articles

A Phase II Single-Arm Open-Labeled Study Evaluating Combination of Quizartinib and Omacetaxine Mepesuccinate (QUIZOM) in Newly Diagnosed or Relapsed/Refractory AML Carrying FlT3-ITD

Chunxiao Zhang, Garret MK Leung, MBBS, Sze Pui Tsui, MSc, Ho-Wan Ip, MBBS,FRCPA, Edmond S. K. Ma, MD, Chun Hang Au, PhD, Chris T.L. Chan, PhD, Ka Lam Nelson Ng, PhD, Sze Fai Yip, MD, Bonnie Kho, MD, Harold K K Lee, MD, Qing LIU, Thomas Wing Yan Leung, Yok Lam Kwong, MD FRCP, Anskar Yu Hung Leung, MD PhD

Blood (2019) 134 (Supplement_1): 3825.

https://doi.org/10.1182/blood-2019-126510

Published: 2019

Journal Articles

A Novel 3D Co-Culture System for Isolation and Amplification of Primary Liquid Cancer Cells

Carlos Caicedo-Carvajal, Ph.D, Qing Liu, Ph.D, Andre Goy, MD, Andrew L Pecora, MD, Anthony R Mato, MD, Tatyana Feldman, MD, K. Stephen Suh, Ph.D

Blood (2010) 116 (21): 426.

https://doi.org/10.1182/blood.V116.21.426.426

Published: 2010

Journal Articles

Inactivation of INK4a/ARF Accelerates the Development of PTEN Deficient T-ALL

Yaling Yang, PhD, Xiuhua Gao, MD, PhD, Xin Han, MD, MS, Xiaoyan Huang, MD., MS, Qing Liu, MS, Yu H. Zhang, MD, C. Cameron Yin, MD, PhD, Ling Chen, M. James You, MD, PhD

Blood (2010) 116 (21): 4197.

https://doi.org/10.1182/blood.V116.21.4197.4197

Published: 2010

Journal Articles

Lenalidomide treatment promotes CD154 expression on CLL cells and enhances production of antibodies by normal B cells through a PI3-kinase–dependent pathway

Blood (2010) 115 (13): 2619–2629.

https://doi.org/10.1182/blood-2009-09-242438

Published: 2010

Includes: Supplemental data

Journal Articles

Acute T-cell leukemias remain dependent on Notch signaling despite PTEN and INK4A/ARF loss

Hind Medyouf, Xiuhua Gao, Florence Armstrong, Samuel Gusscott, Qing Liu, Amanda Larson Gedman, Larry H. Matherly, Kirk R. Schultz, Francoise Pflumio, Mingjian James You, Andrew P. Weng

Blood (2010) 115 (6): 1175–1184.

https://doi.org/10.1182/blood-2009-04-214718

Published: 2010

Includes: Supplemental data

Journal Articles

FTY720 Demonstrates Promising in-Vitro and in-Vivo Pre-Clinical Activity by Down-Modulation of Cyclin D1 and Pakt in Mantle Cell Lymphoma.

Lapo Alinari, MD, Qing Liu, PhD, Ching-Shih Chen, PhD, Fengting Yan, MD, PhD, James T Dalton, PhD, Rosa Lapalombella, PhD, Xiaoli Zhang, PhD, Teresa Lin, BS, John C. Byrd, MD, Robert A. Baiocchi, MD, PhD, Natarajan Muthusamy, PhD

Blood (2009) 114 (22): 3728.

https://doi.org/10.1182/blood.V114.22.3728.3728

Published: 2009

Journal Articles

Acute T-Cell Leukemias Remain Dependent On Notch Signaling Despite PTEN and INK4A/ARF Loss.

Hind Medyouf, Xiuhua Gao, Florence Armstrong, Samuel Gusscott, Qing Liu, BS, Amanda Larson Gedman, Larry Matherly, PhD, Kirk R. Schultz, MD, Francoise Pflumio, PhD, M. James You, MD, PhD, Andrew P. Weng, MD, PhD

Blood (2009) 114 (22): 8.

https://doi.org/10.1182/blood.V114.22.8.8

Published: 2009

Journal Articles

Lenalidomide down-regulates the CD20 antigen and antagonizes direct and antibody-dependent cellular cytotoxicity of rituximab on primary chronic lymphocytic leukemia cells

Blood (2008) 112 (13): 5180–5189.

https://doi.org/10.1182/blood-2008-01-133108

Published: 2008

Journal Articles

Resveratrol Inhibits Proliferation and Induces Apoptosis of Mouse Pten Null T-Cell Acute Lymphocytic Leukemia Cells

Qing Liu, Xiuhua Gao, Cheng C. Yin, Chen Ling, M. James You

Blood (2008) 112 (11): 3967.

https://doi.org/10.1182/blood.V112.11.3967.3967

Published: 2008

Journal Articles

FTY720 demonstrates promising preclinical activity for chronic lymphocytic leukemia and lymphoblastic leukemia/lymphoma

Qing Liu, Xiaobin Zhao, Frank Frissora, Yihui Ma, Ramasamy Santhanam, David Jarjoura, Amy Lehman, Danilo Perrotti, Ching-Shih Chen, James T. Dalton, Natarajan Muthusamy, John C. Byrd

Blood (2008) 111 (1): 275–284.

https://doi.org/10.1182/blood-2006-10-053884

Published: 2008

Journal Articles

Gene Dosage of the Cell Cycle Regulatory Phosphatases Cdc25C and PP2A Determines Sensitivity to Lenalidomide in del(5q) MDS.

Sheng Wei, MD, Kathy Rocha, BS, Ann Williams, Ph.D., Xianhong Chen, Ph.D, P.K. Burnette, Ph.D., Julie Y. Djeu, Ph.D., Qing Liu, Ph.D., John Byrd, M.D., Lubomir Sokol, M.D., Nick Lawrence, Ph.D., Roberta Pireddu, Ph.D, Gordon Dewald, Ph.D., Jaroslaw Maciejewski, M.D., Alan List, M.D.

Blood (2007) 110 (11): 118.

https://doi.org/10.1182/blood.V110.11.118.118

Published: 2007

Journal Articles

FTY720 (2-Amino-2-[2-(4-octylphenyl) ethyl] Propane 1, 3-diol hydrochloride), Mediates Cytotoxicity through Caspase Independent and Protein Phosphatase 2A Dependent Mechanisms in Chronic Lymphocytic Leukemia and Lymphoblastic Leukemia/Lymphoma.

Qing Liu, MS, Xiaobin Zhao, M.S., Frank Frissora, M.S., Yihui Ma, M.S., Ramasamy Santhanam, Ph.D., Danilo Perrotti, M.D.,Ph.D., Ching-Shih Chen, Ph.D., James T. Dalton, Ph.D., John C. Byrd, M.D., Natarajan Muthusamy, DVM.,Ph.D.

Blood (2006) 108 (11): 2095.

https://doi.org/10.1182/blood.V108.11.2095.2095

Published: 2006

Journal Articles

Anti–human CTLA-4 monoclonal antibody promotes T-cell expansion and immunity in a hu-PBL-SCID model: a new method for preclinical screening of costimulatory monoclonal antibodies

Kenneth F. May, Jr, Sameek Roychowdhury, Darshna Bhatt, Ergun Kocak, Xue-Feng Bai, Jin-Qing Liu, Amy K. Ferketich, Edward W. Martin, Jr, Michael A. Caligiuri, Pan Zheng, Yang Liu

Blood (2005) 105 (3): 1114–1120.

https://doi.org/10.1182/blood-2004-07-2561

Published: 2005

Journal Articles

Induction of plasminogen activator inhibitor I gene expression by intracellular calcium via hypoxia-inducible factor-1

Qing Liu, Ulrike Möller, Daniela Flügel, Thomas Kietzmann

Blood (2004) 104 (13): 3993–4001.

https://doi.org/10.1182/blood-2004-03-1017

Published: 2004

NARROW

Venetoclax with Hypomethylating Agents Versus Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia with Myelodysplasia Related Changes: A Propensity Score Matched Analysis Based on International Consensus Classification

Favorable Safety Profile and Durable Responses to Pmb-CT01 (BAFFR-CAR T Cell) Therapy in Patients with B-Cell Lymphomas Ineligible for or Who Failed CD19-Targeted Therapy, Including CD19-Negative Disease

Venetoclax with Hypomethylating Agents Compared with Priming Regimens for Newly Diagnosed Patients with Acute Myeloid Leukemia with Myelodysplasia Related Changes: A Single Center Retrospective Study

Prime Editing of the α-Thalassemia Hb Constant Spring Mutation

Naturally Occurring Mutations in Human T Cell Lymphomas Enhance Engineered T Cell Therapies

The Novel Biomarkers for Predicting Prognosis and Recurrence in Primary Central Nervous System Lymphoma: Exosomal Protein and Exosomal microRNA

A Phase II Single-Arm Open-Labeled Study Evaluating Combination of Quizartinib and Omacetaxine Mepesuccinate (QUIZOM) in Newly Diagnosed or Relapsed/Refractory AML Carrying FlT3-ITD

A Novel 3D Co-Culture System for Isolation and Amplification of Primary Liquid Cancer Cells

Inactivation of INK4a/ARF Accelerates the Development of PTEN Deficient T-ALL

Lenalidomide treatment promotes CD154 expression on CLL cells and enhances production of antibodies by normal B cells through a PI3-kinase–dependent pathway

Acute T-cell leukemias remain dependent on Notch signaling despite PTEN and INK4A/ARF loss

FTY720 Demonstrates Promising in-Vitro and in-Vivo Pre-Clinical Activity by Down-Modulation of Cyclin D1 and Pakt in Mantle Cell Lymphoma.

Acute T-Cell Leukemias Remain Dependent On Notch Signaling Despite PTEN and INK4A/ARF Loss.

Lenalidomide down-regulates the CD20 antigen and antagonizes direct and antibody-dependent cellular cytotoxicity of rituximab on primary chronic lymphocytic leukemia cells

Resveratrol Inhibits Proliferation and Induces Apoptosis of Mouse Pten Null T-Cell Acute Lymphocytic Leukemia Cells

FTY720 demonstrates promising preclinical activity for chronic lymphocytic leukemia and lymphoblastic leukemia/lymphoma

Gene Dosage of the Cell Cycle Regulatory Phosphatases Cdc25C and PP2A Determines Sensitivity to Lenalidomide in del(5q) MDS.

FTY720 (2-Amino-2-[2-(4-octylphenyl) ethyl] Propane 1, 3-diol hydrochloride), Mediates Cytotoxicity through Caspase Independent and Protein Phosphatase 2A Dependent Mechanisms in Chronic Lymphocytic Leukemia and Lymphoblastic Leukemia/Lymphoma.

Anti–human CTLA-4 monoclonal antibody promotes T-cell expansion and immunity in a hu-PBL-SCID model: a new method for preclinical screening of costimulatory monoclonal antibodies

Induction of plasminogen activator inhibitor I gene expression by intracellular calcium via hypoxia-inducible factor-1

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only